Cochrane COVID-19 Study Register
Study record
NCT05043129First Published: 2021 Sep 14Updated Date: 2021 Sep 14

Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection

  1. Study Type
  2. Observational
  1. Study Aim
  2. Prevention
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
Reference record

Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection

NCT05043129
Trial registry record
No Results
On 11 February 2020, the International Committee for the Classification of Viruses named the disease caused by SARS-CoV-2 infection in humans as the new coronavirus pneumonia (coronavirus disease 2019, COVID-19). People infected with human immunodeficiency virus (HIV) are affected by their underlying diseases and are listed by the World Health Organization (WHO) as a high-risk population of SARS-CoV-2 infection.To evaluate the safety and effectiveness of COVID-19 vaccine in those patients with human immunodeficiency virus infection , and to guide the COVID-19 vaccination more scientifically, reasonably and effectively, this study was carried out